What We're Reading: Page 147
Industry reads hand-picked by our editors
Mar 02, 2021
-
The New York Times
Why has coronavirus testing slumped in the U.S.? It’s complicated.
-
MedPage Today
Low-Risk TAVR at 2 Years: Thrombosis Concerns Creep In
-
TCTMD
No Harm, No Help With Bioabsorbable-Polymer Stents: Registry
-
MobiHealthNews
Pear Therapeutics tags another $20M to December's Series D round
Mar 01, 2021
-
Associated Press
Plunging demand for COVID-19 tests may leave US exposed
-
Wall Street Journal
New York City Invests in Rapid Covid-19 Test to Aid Economic Recovery
-
The New York Times
Want to Buy a Scrunchie Mask? Great. But Forget About That N95.
-
TechCrunch
Clue gets FDA clearance to launch a digital contraceptive
Feb 26, 2021
Feb 25, 2021
-
The Mercury News
California has quietly ended its COVID-19 testing partnership with Verily
-
MedPage Today
ECG Patch Boosts Afib Diagnoses in Older Folks
-
MobiHealthNews
Global lessons learned about DTx implementation, reimbursement
-
MedCity News
With results of pivotal study, AppliedVR to seek FDA clearance
Feb 24, 2021
-
The New York Times
Studies Examine Variant Surging in California, and the News Isn’t Good
-
The Washington Post
Biden to order sweeping review of U.S. supply chain weak spots
-
STAT
How Covid-19 could usher in a new role for continuous glucose monitoring in hospitals
-
VentureBeat
Truvian raises $105 million to commercialize its automated blood-testing platform
Feb 23, 2021
Feb 22, 2021
-
Wall Street Journal
How Some Covid-19 Tests Can Flag a Key Variant
-
The New York Times
Who Will Be the Next F.D.A. Chief?
-
MedCity News
Will IBM’s reported desire to sell Watson cast a shadow over big tech’s healthcare ambitions?
-
USA TODAY
COVID-19 detection: Could your Apple Watch or Fitbit help slow the coronavirus pandemic?
Previous
